Senior Epidemiologist, Inflammation, RWE & Regulatory Strategy; FSP Sponsor Dedicated

Location:

Remote, candidates must be US-based. Join IQVIA’s Sponsor‑Dedicated FSP team and help advance healthcare through real‑world evidence. We bring together scientific expertise and real‑world data to help sponsors make decisions and accelerate evidence generation to improve patient outcomes. In this role, you’ll work closely with one sponsor, gaining deep knowledge of their therapies while leveraging IQVIA’s global expertise.

This role will support a Real World Evidence team focused on Inflammation, with flexibility across indications (e.g., lupus, IBD, Crohn’s). It will play a key part in designing and executing real‑world evidence (RWE) studies that inform clinical development strategy, including generating evidence to address regulatory questions related to safety profiles and evidence gaps for Phase 2 and Phase 3 programs. This position requires a senior‑level epidemiologist to provide scientific oversight across complex observational research, leveraging secondary data sources such as commercial real‑world data platforms.

The role involves applying epidemiologic expertise to study design, execution, and interpretation, with a strong focus on ensuring that evidence generated is fit‑for‑purpose for regulatory and clinical decision‑making. Qualified candidates will bring experience supporting clinical development and/or drug safety, along with a strong understanding of how RWE is used to support regulatory submissions. While therapeutic area experience in inflammation is a plus, it is not required.

This position requires close collaboration with cross‑functional stakeholders, with the ability to operate independently within a sponsor‑dedicated environment.

• Doctoral degree in Epidemiology
• 5–7 years of experience within a pharma company or pharma consulting environment
• Experience conducting real‑world evidence studies using secondary data sources, including commercial RWD platforms (e.g., Health Verity, Phar Metrics Plus, TriNetX)
• Strong understanding of regulatory requirements supporting clinical development, including the types of evidence required to address safety and evidence gaps for Phase 2 and Phase 3 programs
• Experience supporting clinical development and/or drug safety through observational research
• Ability to work with and interpret large healthcare datasets; advanced programming not required
• Strong ability to collaborate across cross‑functional teams and contribute to study design, execution, and interpretation

• Therapeutic area experience in inflammation, including lupus, IBD, or Crohn’s disease
• Experience working with primary or hybrid data sources, in addition to secondary data
• Experience supporting regulatory submissions or evidence packages

Be part of a forward‑thinking team that helps shape the next generation of evidence‑based healthcare. Work hand‑in‑hand with one leading sponsor, gaining deep expertise in their therapies. Access IQVIA’s global network for your growth. This is your chance to make an impact, while building a career that matters.

The potential base pay range for this role, when annualized, is $ – $. The actual base pay offered may vary based on a number of factors including job‑related qualifications such as knowledge, skills, education, and experience; location; and/or schedule (full or part‑time). Dependent on the position offered, incentive plans, bonuses, and/or other forms of compensation may be offered, in addition to a range of health and welfare and/or other benefits.

IQVIA is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, status as a protected veteran, or any other status protected by applicable law.